References
Ahoka, A., Kaukoranta, J., Wahlbeck K., Aito M. (2001). Estrogen deficiency in severe PPD: Successful treatment with sublingual physiologic 17 beta estradiol: A preliminary study. Journal of Clinical Psychiatry, 62, 5.
Altshuler, L. L., Cohen, L., Szuba, M. P., Burt, V. K., Gitlin, M., Mintz, J. (1996). Pharmacologic management of psychiatric illness in pregnancy: Dilemmas and guidelines. The American Journal of Psychiatry, 153, 592–606.
Appleby, L. (1991). Suicide during pregnancy and in the first postnatal year. British Medical Journal, 302, 137–140.PubMedCentralPubMed
Appleby, L., Warner, R., Whitton, A., & Faragher, B. (1997). A controlled study of fluoxetine and cognitive-behavioural counseling in the treatment of postnatal depression. BMJ, 314, 932–936.PubMedCentralPubMed
Armstrong, C. (2008). ACOG guidelines on psychiatric medication use during pregnancy and lactation. American Family Physician, 78(6), 772–778.
Arnold, L. M. (2003). Gender differences on bipolar disorder. Psychiatric Clinics of North America, 26(3), 595–620.PubMed
Ashby, C., Jr., Carr, L. A., Cook, C. L., Steptoe, M. M., Franks, D. D. (1988). Alteration of platelet serotonergic mechanism and monoamine oxidase activity in premenstrual syndrome. Biological Psychiatry, 24(2), 225–233.
Avis, N. E., Brambilla, D., McKinlay, S. M., Vass, K. (1994a). A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women’s Health Study. Annals of Epidemiology, 4(3), 214–220.
Backstrom, T., Andreen, L., Birzniece, V., Bjorn, I., Johansson, I. M., Nordenstam-Haghjo, M., Nyberg, S., Sundstrom-Poromaa, I., Wahlstrom, G., Wang, M., Zhu, D. (2003). The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs, 17(5), 325–342.
Bailara, K. M., Henry, C., Lestage, J., Launay, J. M., Parrot, F., Swendsen, J., Sutter, A. L., Roux, D., Dallay, D., Demotes-Mainard, J. (2005). Decreased brain tryptophan availability as a partial determinant of postpartum blues. Psychoneuroendocrinology, 31(3), 407–413. Epub November 21, 2005.
Baller, E. B., Wei, S. M., Kohn, P. D., Rubinow, D.R., Alarcón G, Schmidt, P. J., Berman, K.F. (2013). Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: A multimodal neuroimaging study. The American Journal of Psychiatry, 170(3), 305–314.
Barnas, C., Bergant, A., Hummer, M., Saria, A., & Fleischhacker, W. W. (1994). Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. The American Journal of Psychiatry, 151(6), 945.PubMed
Beck, C. T. (2004). PTSD due to childbirth:The Aftermath. Nursing Research, 53(4), 216–224.PubMed
Berle, J., & Spigset, O. (2011). Antidepressant Use During Breastfeeding. Current Women’s Health Reviews, 7(1), 28–34.PubMedCentralPubMed
Borenstein, J. E., Dean, B. B., Endicott, J., Wong, J., Brown, C., Dickerson, V., Yonkers, K. A. (2003). Health and economic impact of the premenstrual syndrome. Journal of Reproductive Medicine, 48(7), 515–524.
Brinsmead, M., Smith, R., Singh, B., Lewin, T., & Owens, P. (1985). Peripartum concentrations of beta endorphin and cortisol and maternal mood states. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 25(3), 194–197.
Bromley, R., Mawer, G. E., Briggs, M., Cheyne, C., Clayton-Smith, J., Garcia-Finana, M., Kneen, R., Lucas, S. B., Shallcross, R., Baker, G. A. (2013). The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. Journal of Neurology, Neurosurgery and Psychiatry, 84(6), 637–643.
Casper, R. C. (2003). Fleisher BE, et al; Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. Journal of Pediatrics, 142(4), 402–408.PubMed
Chambers, C. D., Hernandez-Diaz, S., Van Marter, L. J., Werler, M. M., Louik, C., Jones, K. L., Mitchell, A. A. (2006). Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. New England Journal of Medicine, 354, 579–587.PubMed
Chaudron, L. (2013). Complex challenges in treating depression during pregnancy. The American Journal of Psychiatry, 170, 12–20.PubMed
Chaudron, L., & Jefferson, J. (2000). Mood stabilizers during breastfeeding: A review. Journal of Clinical Psychiatry, 61, 79–90.PubMed
Chaudron, L., & Pies, R. (2003). The relationship between postpartum psychosis and bipolar disorder: A review. Journal of Clinical Psychiatry, 64, 1284–1292.PubMed
Chaudron, L., Szilagyi, P. G., Kitzman, H., Wadkins, H. I., Conwell, Y. (2004). Detection of postpartum depressive symptoms by screening at well-child visits. Pediatrics, 113(3), 551–558.PubMed
Cicchetti, D., Rogosch, F., & Toth, S. (1998). Maternal depressive disorder and contextual risk: Contributions to the development of attachment insecurity and behavior problems in toddlerhood. Development and Psychopathology, 10, 283–300.PubMed
Cohen, L. S. (2007). Treatment of bipolar disorder during pregnancy. Journal of Clinical Psychiatry, 68(suppl 9), 4–9.PubMed
Cohen, L., Friedman, J. M., Jefferson, J., Johnson, E. M., Weiner, M. L. (1994). A re-evaluation of risk of in utero exposure to lithium. JAMA, 271, 146–150.
Cohen, L., Nonacs, R. M., Bailey, J. W., Viguera, A. C., Reminick, A. M., Altshuler, L. L., Stowe, Z. N., Faraone, S. V. (2004). Relapse of depression during pregnancy following antidepressant discontinuation: A preliminary prospective study. Archives of Women’s Mental Health, 7, 217–221.
Cohen, L., Sichel, D., Robertson, L., Heckscher, E., Rosenbaum, J. F. (1995). Postpartum prophylaxis for women with bipolar disorder. The American Journal of Psychiatry, 152, 1641–1645.PubMed
Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., Harlow, B. L. (2006). Risk for new onset of depression during the menopausal transition: The Harvard Study of Moods and Cycles. Archives of General Psychiatry, 63(4), 385–390.PubMed
Cooper, P., & Murray, L. (1995). Course and recurrence of postnatal depression. British Journal of Psychiatry, 166, 191–195.PubMed
Cox, J. L., Holden, J. M., & Sagovsky, R. (1987). Detection of postnatal depression: Development of the 10–item Edinburgh Postnatal Depression scale. British Journal of Psychiatry, 150, 782–786.PubMed
Craig, M., & Howard, L. (2009a). Postnatal depression. Clinical Evidence (Online), 2009.
Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., Hendrick, V. (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry, 68(11), 1104–1112.
Croke, S., Buist, A., Hackett, L. P., Ilett, K. F., Norman, T. R., & Burrows, G. D. (2002). Olanzapine excretion in human breast milk: Estimation of infant exposure. International Journal of Neuropsychopharmacology, 5(3), 243.PubMed
Dante, G., & Facchinetti, F. (2011a). “Herbal treatments for alleviating premenstrual symptoms: A systematic review. Journal of Psychosomatic Obstetrics and Gynaecology, 32(1), 42–51.PubMed
Dennis, C. (2003). The effect of peer support on PPD: A pilot randomized controlled trial. Canadian Journal of Psychiatry, 48(2), 115–124.
Dennis, C. L., & Dowswell, T. (2013). Psychosocial and psychological interventions for preventing postpartum depression. Cochrane Database of Systematic Reviews, 2, CD001134.PubMed
Dennis, C. L., Janssen, P. A., Singer, J. (2004a). Identifying women at-risk for postpartum depression in the immediate postpartum period. Acta Psychiatrica Scandinavica, 110(5), 338–346.PubMed
DeVera, M. A., & Berard, A. (2012). Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension. British Journal of Clinical Pharmacology, 74(2), 362–369.
Ebbesen, F., Joergensen, A., Hoseth, E., Kaad, P. H., Moeller, M., Holsteen, V., Rix, M. (2000). Neonatal hypoglycemia and withdrawal symptoms after exposure in utero to valproate. Archives of Disease in Childhood (Fetal and Neonatal Ed), 83, F124–F129.
Edhborg, M., Lundh, W., Seimyr, L., Widstrom, A. M. (2003). The parent-child relationship in the context of maternal depressive mood. Archives of Women’s Mental Health, 6, 211–216.
Eskandari, F., Martinez, P. E., Torvik, S., Phillips, T. M., Sternberg, E. M., Mistry, S., Ronsaville, D., Wesley, R., Toomey, C., Sebring, N. G., Reynolds, J. C., Blackman, M. R., Calis, K. A., Gold, P. W., Cizza, G. (2007a). Low bone mass in premenopausal women with depression. Archives of Internal Medicine, 167(21), 2329–2336.
Essex, M., Klein, M., Cho, E., Kalin, N. H., (2002). Maternal stress beginning in infancy may sensitize children to later stress exposure: Effects on cortisol and behavior. Biological Psychiatry, 52, 776–784.PubMed
Feldman, R., Granat, A., Pariente, C., Kanety, H., Kuint, J., Gilboa-Schechtman, E. (2009a). Maternal depression and anxiety across the postpartum year and infant social engagement, fear regulation, and stress reactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 48(9), 919–927.
Fitelson, E., Kim, S., Baker, A. S., & Leight, K. (2011). Treatment of postpartum depression: Clinical, psychological and pharmacological options. International Journal of Women’s Health, 3, 1–14.PubMedCentral
Freeman, E. W., Sammel, M. D., Lin, H., Nelson, D. B. (2006). Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry, 63(4), 375–382.PubMed
Gaynes, B. N., Gavin, N., Meltzer-Brody, S., Lohr, K. N., Swinson, T., Gartlehner, G., Brody, S., Miller, W. C. (2005a). Perinatal depression: Prevalence, screening accuracy, and screening outcomes. Evidence Report/Technology Assessment (Summary), 119, 1–8.
Gentile, S. (2008). Pregnancy exposure to serotonin reuptake inhibitors and the risk of spontaneous abortions. CNS Spectrums, 13, 960–966.PubMed
Gentile, S. (2010). Antipsychotic therapy during early and late pregnancy: A systematic review. Schizophrenia Bulletin, 36(3), 518–544.PubMedCentralPubMed
Gentile, S. (2012). Lithium in Pregnancy: The need to treat, the duty to ensure safety. Expert Opinion on Drug Safety, 11(3), 425–437.PubMed
Gotlib, I., Whiffen, V. E., Mount, J. H., Milne, K., Cordy, N. I. (1989). Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. Journal of Consulting and Clinical Psychology, 57(2), 269–274.
Gregoire, A. J. P., & Kumar, R. (1996). Transdermal estrogen for treatment of severe postpartum depression. Lancet, 347, 930–933.PubMed
Grigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Roerecke, M., Rehm, J., Dennis, C. L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A., Ross, L. E. (2013a). Antidepressant exposure during pregnancy and congenital malformations: Is there an association? A systematic review and meta-analysis of best evidence. Journal of Clinical Psychiatry, 74(4), e293–e308.
Grigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Eady, A., Tomlinson, G., Dennis, C. L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A., Ross, L. E. (2013b). The effect of prenatal antidepressant exposure on neonatal adaptation: A systematic review and meta-analysis. Journal of Clinical Psychiatry, 74(4), e309–e320.
Guclu, S., Gol, M., Dogan, E., Saygili, U. (2005). Mirtazapine use in resistant hyperemesis gravidarum: Report of three cases and review of the literature. Archives of Gynecology and Obstetrics, 272(4), 298–300.PubMed